{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:37Z","timestamp":1790223397206,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":580,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/jid.2013.488","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T14:45:36Z","timestamp":1384353936000},"page":"1428-1435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["The Role of IL-32 in Cutaneous T-Cell Lymphoma"],"prefix":"10.1016","volume":"134","author":[{"given":"Hiraku","family":"Suga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Miyagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kadono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2013.488_bb0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/1523-1747.ep12330869","article-title":"Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA","volume":"107","author":"Asadullah","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.488_bb0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1182\/blood.V88.2.757.bloodjournal882757","article-title":"Interferon gamma and tumor necrosis factor alpha mRNA expression in mycosis fungoides progression","volume":"88","author":"Asadullah","year":"1996","journal-title":"Blood"},{"key":"10.1038\/jid.2013.488_bb0020","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.200804-646OC","article-title":"IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease","volume":"178","author":"Calabrese","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1038\/jid.2013.488_bb0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"S\u00e9zary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1038\/jid.2013.488_bb0030","doi-asserted-by":"crossref","first-page":"12049","DOI":"10.1074\/jbc.M110.159756","article-title":"Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells","volume":"286","author":"Cheon","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2013.488_bb0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","article-title":"Identification of a novel gene expressed in activated natural killer cells and T cells","volume":"148","author":"Dahl","year":"1992","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.488_bb0040","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.488_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0140-6736(94)90879-6","article-title":"Lesional expression of interferon-gamma in atopic eczema","volume":"343","author":"Grewe","year":"1994","journal-title":"Lancet"},{"key":"10.1038\/jid.2013.488_bb0050","series-title":"Mol Carcinog","article-title":"Interleukin-32 expression is associated with a poorer prognosis in head and neck squamous cell carcinoma","author":"Guenin","year":"2013"},{"key":"10.1038\/jid.2013.488_bb0055","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.ajpath.2011.05.040","article-title":"Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma","volume":"179","author":"G\u00fcnther","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2013.488_bb0060","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/hupa.2000.20370","article-title":"Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis","volume":"31","author":"Izban","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1038\/jid.2013.488_bb0065","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1073\/pnas.0511233103","article-title":"IL-32, a proinflammatory cytokine in rheumatoid arthritis","volume":"103","author":"Joosten","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.488_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2013.488_bb0075","first-page":"865","article-title":"IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells","volume":"20","author":"Kempuraj","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1038\/jid.2013.488_bb0080","first-page":"131","article-title":"Interleukin-32: a cytokine and inducer of TNFalpha","volume":"22","author":"Kim","year":"2005","journal-title":"Immunity"},{"key":"10.1038\/jid.2013.488_bb0085","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.4049\/jimmunol.0902667","article-title":"IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection","volume":"185","author":"Li","year":"2010","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.488_bb0090","doi-asserted-by":"crossref","first-page":"e4173","DOI":"10.1371\/journal.pone.0004173","article-title":"Interleukin-32 promotes osteoclast differentiation but not osteoclast activation","volume":"4","author":"Mabilleau","year":"2009","journal-title":"PLoS One"},{"key":"10.1038\/jid.2013.488_bb0095","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1600-0560.2007.00924.x","article-title":"A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS","volume":"35","author":"Mao","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1038\/jid.2013.488_bb0100","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1073\/pnas.0712391105","article-title":"Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function","volume":"105","author":"Marcondes","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.488_bb0105","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.jaci.2010.01.016","article-title":"IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis","volume":"125","author":"Meyer","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/jid.2013.488_bb0110","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/jid.2010.128","article-title":"Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma","volume":"130","author":"Miyagaki","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.488_bb0115","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/j.1468-3083.2012.04495.x","article-title":"Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis","volume":"27","author":"Miyagaki","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/jid.2013.488_bb0120","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar3850","article-title":"Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha","volume":"14","author":"Nakayama","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/jid.2013.488_bb0125","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","article-title":"Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1\/IL-18\/interferon-gamma-dependent mechanism","volume":"3","author":"Netea","year":"2006","journal-title":"PLoS Med"},{"key":"10.1038\/jid.2013.488_bb0130","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.0712381105","article-title":"Interleukin-32 induces the differentiation of monocytes into macrophage-like cells","volume":"105","author":"Netea","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.488_bb0135","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1038\/onc.2011.52","article-title":"IL-32\u03b3 inhibits cancer cell growth through inactivation of NF-\u03baB and STAT3 signals","volume":"30","author":"Oh","year":"2011","journal-title":"Oncogene"},{"key":"10.1038\/jid.2013.488_bb0140","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1038\/jid.2013.488_bb0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2567.2011.03513.x","article-title":"Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3","volume":"135","author":"Park","year":"2012","journal-title":"Immunology"},{"key":"10.1038\/jid.2013.488_bb0150","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/cgt.2011.37","article-title":"Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32","volume":"18","author":"Qu","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/jid.2013.488_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.imlet.2008.01.007","article-title":"Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication","volume":"117","author":"Rasool","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1038\/jid.2013.488_bb0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","article-title":"Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease","volume":"149","author":"Shioya","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/jid.2013.488_bb0165","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200903-0400OC","article-title":"Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype","volume":"180","author":"Sorrentino","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1038\/jid.2013.488_bb0170","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","article-title":"Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis","volume":"107","author":"Sors","year":"2006","journal-title":"Blood"},{"key":"10.1038\/jid.2013.488_bb0175","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/jid.2011.349","article-title":"Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens","volume":"132","author":"Sugaya","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.488_bb0180","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/jid.2012.117","article-title":"A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides","volume":"132","author":"van Kester","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.488_bb0185","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15367841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15367841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:31:15Z","timestamp":1743975075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15367841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0022202X15367841"],"URL":"https:\/\/doi.org\/10.1038\/jid.2013.488","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of IL-32 in Cutaneous T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2013.488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}